Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Mini Review Volume 6 Issue 6

Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea: A New Kid on the Block

Suganya Karikalan1 and Salim Surani2*

1Karpaga Vinayaga Institute of Medical Science, India
2Texas A&M University, College Station, Texas, USA

*Corresponding Author: Salim Surani, Texas A&M University, College Station, Texas, USA.

Received: March 10, 2022; Published: May 04, 2022

Abstract

Around 29.5 million people in the United States over the age of 30 years suffer from mild to severe Obstructive Sleep Apnea. Positive Airway Pressure (PAP) remains the mainstay of treatment of OSA. Despite being the gold standard treatment for many years, the compliance rate for the PAP devise remains low. Other modes of treatment such as the use of Mandibular Devices, surgery for relieving the obstruction, and weight reduction surgeries carry high morbidity and mortality. The new evolving Upper Airway Stimulation therapy – Hypoglossal Nerve stimulation opens new and alternate pathways of treatment approach to OSA. This opinion-minireview explores two new devices, the INSIGHT MEDICAL SYSTEMS DEVICE, and the eXciteOSA device.

Keywords: Positive Airway Pressure (PAP); Obstructive Sleep Apnea (OSA); Mortality

References

  1. Anstead M and Phillips B. “The spectrum of sleep-disordered breathing”. Respiratory Care Clinics of North America3 (1999): 363-377.
  2. Watson NF. “Health care savings: the economic value of diagnostic and therapeutic care for obstructive sleep apnea”. Journal of Clinical Sleep Medicine8 (2016): 1075-1077.
  3. Pachito D v., et al. “Economic evaluation of CPAP therapy for obstructive sleep apnea: a scoping review and evidence map”. Sleep and Breath1 (2022): 17-30.
  4. Nguyen ATD., et al. “Pathogenesis 11. Obstructive Sleep Apnea: Pathophysiology, Comorbidities, and Consequences: Pathophysiology, Comorbidities, and Consequences”. Published online (2007): 171.
  5. Guilleminault C and Takaoka S. “2 Signs and symptoms of obstructive sleep apnea and upper airway resistance syndrome”. Sleep Apnea and Snoring E-Book: Surgical and Non-Surgical Therapy (2008): 3.
  6. Mwenge GB., et al. “Targeted hypoglossal neurostimulation for obstructive sleep apnoea: A 1-year pilot study”. European Respiratory Journal2 (2013): 360-367.
  7. Maurer JT and de Vries N. “Upper Airway Stimulation—Implanted Neurostimulation Device for Treatment of Obstructive Sleep Apnea”. Advanced Surgical Techniques in Snoring and Obstructive Sleep Apnea (2013): 303.
  8. Eastwood PR., et al. “Bilateral hypoglossal nerve stimulation for treatment of adult obstructive sleep apnoea”. European Respiratory Journal1 (2020).
  9. Campanini A., et al. “Drug-Induced Sedation Endoscopy (DISE)”. In: TransOral Robotic Surgery for Obstructive Sleep Apnea. Springer; (2016): 41-50.
  10. Pang KP., et al. “Advanced Surgical Techniques in Snoring and Obstructive Sleep Apnea”. Plural Publishing (2013).
  11. Dijemeni E., et al. “Drug-induced sedation endoscopy (DISE) classification systems: a systematic review and meta-analysis”. Sleep and Breathing 21 (2017): 983-994.
  12. Ferguson MS., et al. “Narrative review of contemporary treatment options in the care of patients with obstructive sleep apnoea”. Therapeutic Advances in Respiratory Disease11 (2017): 411-423.
  13. Kim SY and Naqvi IA. “Neuroanatomy, cranial nerve 12 (Hypoglossal)”. Published online (2018).
  14. Kotecha B., et al. “A novel intraoral neuromuscular stimulation device for treating sleep-disordered breathing”. Sleep Breath4 (2021): 2083-2090.
  15. Strollo PJ., et al. “Upper-Airway Stimulation for Obstructive Sleep Apnea ABSTRACT”. The New England Journal of Medicine 370 (2014): 139-188.
  16. Thaler E., et al. “Results of the ADHERE Upper Airway Stimulation Registry and Predictors of Therapy Efficacy” (2019).
  17. Heiser C., et al. “Post-approval upper airway stimulation predictors of treatment effectiveness in the ADHERE registry”. European Respiratory Journal1 (2019).
  18. Woodson BT., et al. “Upper airway stimulation for obstructive sleep apnea: 5-year outcomes”. Otolaryngology–Head and Neck Surgery1 (2018): 194-202.
  19. Baptista PM., et al. “Clinical Medicine Daytime Neuromuscular Electrical Therapy of Tongue Muscles in Improving Snoring in Individuals with Primary Snoring and Mild Obstructive Sleep Apnea”. Journal of Clinical Medicine 10 (2021): 1883.

Citation

Citation: Suganya Karikalan and Salim Surani. “Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea: A New Kid on the Block”.Acta Scientific Medical Sciences 6.6 (2022): 23-26.

Copyright

Copyright: © 2022 Suganya Karikalan and Salim Surani. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is November 30, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US